Nearly three-quarters of infants were immunized against respiratory syncytial virus through maternal vaccination or ...

A federal vaccine advisory committee plans to review the childhood vaccination schedule and scrutinize vaccines that have ...

This builds upon its initial approval in May 2024 for adults aged 60 years and older, which makes mRESVIA the second approved ...

The letter, signed by 79 medical societies, expresses concern over recent federal immunization review policies and asks that vaccines remain available to patients without cost-sharing.

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers began their first meeting Wednesday under intense scrutiny ...

The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults ...

A virus that once filled pediatric hospital beds and terrified new parents is finally being pushed back—before babies are ...

The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on ...